Ezio Ghigo
Founder at Millendo Therapeutics SAS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thierry Abribat | M | - |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | 17 years |
| André de Villers | M | - |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | 17 years |
| Francesca Culasso | F | 50 |
University of Turin
| - |
| Giorgio Gilli | M | 77 |
University of Turin
| 50 years |
| François Miceli | M | 60 |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | - |
| Carlo Felice Maggi | M | - |
University of Turin
| 14 years |
| Fabrizio Mosca | M | 46 |
University of Turin
| - |
| Lionello Jona Celesia | M | 88 |
University of Turin
| - |
| Emilio Hirsch | M | 59 |
University of Turin
| 19 years |
| Valter Cantino | M | - |
University of Turin
| - |
| Bernardo Bortolotti | M | 56 |
University of Turin
| - |
| Gianmarco Montanari | M | 52 |
University of Turin
| 7 years |
| Antonio Palumbo | M | - |
University of Turin
| - |
| Donatella Busso | F | 51 |
University of Turin
| 28 years |
| Nicola Miglietta | M | 56 |
University of Turin
| - |
| Gilles Alberici | M | 67 |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | - |
| Enrico Grosso | M | 57 |
University of Turin
| - |
| Flavio Dezzani | M | 83 |
University of Turin
| - |
| Mario Rey | M | 86 |
University of Turin
| - |
| Angelo Miglietta | M | 62 |
University of Turin
| - |
| Mounia Chaoui-Roulleau | M | 52 |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | - |
| Aart Jan van der Lely | M | - |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | 17 years |
| Soraya Allas | M | - |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | 16 years |
| Toti Salvatore Musumeci | M | 66 |
University of Turin
| 26 years |
| Gianfranco Gilardi | M | - |
University of Turin
| - |
| Paolo Fabris de Fabris | M | - |
University of Turin
| 19 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Italy | 19 | 73.08% |
| France | 7 | 26.92% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ezio Ghigo
- Personal Network
